Home › Funds › Latash Investments, LLC › ANAB

Latash Investments, LLC position in ANAB

ANAPTYSBIO INC · Health Care

Latash Investments, LLC reported holding 4,393 shares of ANAB (ANAPTYSBIO INC) in its Q3 2026 13F filing — a position valued at US$221K, representing 0.16% of its reported portfolio and ranking #18 among its reported holdings. Latash Investments, LLC has disclosed ANAB holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)4.39K sh
Reported value held$220.79K
Portfolio Weight0.16%
First reportedQ4 2025
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Latash Investments, LLC's ANAB position evolved

Latash Investments, LLC first disclosed a stake in ANAB in Q4 2025 at 4,393 shares (US$213K). The position peaked in Q2 2026 at 4,393 shares, worth US$297K. Across 4 filings, Latash Investments, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 4,393 shares valued at US$221K.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 4.39K $212.97K New
Q1 2026 4.39K $243.64K Hold
Q2 2026 4.39K $296.53K Hold
Q3 2026 4.39K $220.79K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ANAB and 13F data

ANAB (ANAPTYSBIO INC) is a Health Care company. 42 other funds we track also report a position in ANAB — the largest reported positions include EcoR1 Capital, LLC (US$531.9M), TANG CAPITAL MANAGEMENT LLC (US$89.8M), Affinity Asset Advisors, LLC (US$55.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANAB

All ANAB fund holders →

FAQ

How long has Latash Investments, LLC held ANAB?

Latash Investments, LLC has disclosed ANAB holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Latash Investments, LLC's current position in ANAB?

As of Q3 2026, Latash Investments, LLC holds 4.39K shares of ANAB (ANAPTYSBIO INC), valued at $220.79K, representing 0.16% of its reported portfolio and ranking #18.

Has Latash Investments, LLC been buying or selling ANAB?

In the latest 13F filing (Q3 2026), Latash Investments, LLC held unchanged its position in ANAB. The position peaked in Q2 2026 at 4.39K shares.

Which other funds hold ANAB?

Other major institutional holders of ANAB include EcoR1 Capital, LLC, TANG CAPITAL MANAGEMENT LLC, Affinity Asset Advisors, LLC, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.